Yihong Yao Net Worth

The estimated Net Worth of Yihong Yao is at least $951 Thousand dollars as of 22 December 2017. Mr. Yao owns over 4,167 units of Cellular Biomedicine Inc stock worth over $585,923 and over the last 9 years he sold CBMG stock worth over $0. In addition, he makes $364,975 as Chief Scientific Officer at Cellular Biomedicine Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Yao CBMG stock SEC Form 4 insiders trading

Yihong has made over 1 trades of the Cellular Biomedicine Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he bought 4,167 units of CBMG stock worth $50,004 on 22 December 2017.

The largest trade he's ever made was buying 4,167 units of Cellular Biomedicine Inc stock on 22 December 2017 worth over $50,004. On average, Yihong trades about 833 units every 0 days since 2015. As of 22 December 2017 he still owns at least 29,667 units of Cellular Biomedicine Inc stock.

You can see the complete history of Mr. Yao stock trades at the bottom of the page.

Yihong Yao biography

Dr. Yihong Yao Ph.D. serves as Chief Scientific Officer of the Company. Mr. Yao brings nearly twenty years of experience in the life sciences industry and academia with strong expertise in clinical biomarker discovery and development, strategy and personalized medicine. From 2005 until his appointment as Chief Scientific Officer, Mr. Yao served in various senior scientific positions at MedImmune, including most recently as director and head of pharmacogenomics and bioinformatics in the department of Translational Sciences from 2011 to July 2015. From 2001 to 2005, Mr.Yao served as Senior Scientist, Translational Science at Abbott Bioresearch Center. He holds a bachelor’s degree in Biochemistry from Fudan University, Shanghai, China, a master’s degree in Bioinformatics from Boston University, and a PhD in Molecular Biology and Biochemistry from the University of Kansas, and he was a postdoctoral fellow at Johns Hopkins University School of Medicine.

What is the salary of Yihong Yao?

As the Chief Scientific Officer of Cellular Biomedicine Inc, the total compensation of Yihong Yao at Cellular Biomedicine Inc is $364,975. There are 2 executives at Cellular Biomedicine Inc getting paid more, with Andrew Chan having the highest compensation of $847,684.

How old is Yihong Yao?

Yihong Yao is 52, he's been the Chief Scientific Officer of Cellular Biomedicine Inc since 2015. There are 6 older and 3 younger executives at Cellular Biomedicine Inc. The oldest executive at Cellular Biomedicine Group Inc is Edward Schafer, 74, who is the Non-Executive Independent Director.

What's Yihong Yao's mailing address?

Yihong's mailing address filed with the SEC is C/O CELLULAR BIOMEDICINE GROUP, INC., 9605 MEDICAL CENTER DR, SUITE 100, ROCKVILLE, MD, 20850.

Insiders trading at Cellular Biomedicine Inc

Over the last 13 years, insiders at Cellular Biomedicine Inc have traded over $5,441,696 worth of Cellular Biomedicine Inc stock and bought 262,367 units worth $1,621,804 . The most active insiders traders include Keith Wong, Wei (William) Cao, and Pak To Venture Garden Ltd F.... On average, Cellular Biomedicine Inc executives and independent directors trade stock every 84 days with the average trade being worth of $911,976. The most recent stock trade was executed by Wen Tao Liu on 10 April 2018, trading 22,444 units of CBMG stock currently worth $348,555.

What does Cellular Biomedicine Inc do?

Complete history of Mr. Yao stock trades at Cellular Biomedicine Inc

Cellular Biomedicine Inc executives and stock owners

Cellular Biomedicine Inc executives and other stock owners filed with the SEC include:

• Andrew Chan,
  Senior Vice President - Corporate Business Development, General Counsel, Chief Legal Officer, Secretary
• Bizuo Liu,
  Chief Executive Officer, Chief Financial Officer, Director
• Yihong Yao,
  Chief Scientific Officer
• Wen Liu,
  Independent Director
• Terry Belmont,
  Independent Chairman of the Board
• Hansheng Zhou,
  Independent Director
• Chun Kwok Alan Au,
  Independent Director
• Edward Schafer,
  Non-Executive Independent Director
• Gang Ji,
  Independent Director
• Sarah Kelly,
  Director of Corporate Communications
• Darren O'Brien,
  Independent Director
• Health Investment Holdings ...,
  
• Wei (William) Cao,
  Chief Executive Officer
• Bosun Hau,
  
• Tony Liu,
  CEO, CFO
• Nadir Patel,
  
• Pak To Venture Garden Ltd F...,
  
• David Bolocan,
  Director
• Keith Wong,
  Director
• Jianping Dai,
  Director